124 related articles for article (PubMed ID: 26472477)
21. Pharmacologic management of diabetic peripheral neuropathic pain.
Iyer S; Tanenberg RJ
Expert Opin Pharmacother; 2013 Sep; 14(13):1765-75. PubMed ID: 23800105
[TBL] [Abstract][Full Text] [Related]
22. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
[TBL] [Abstract][Full Text] [Related]
24. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
25. Evidence-based pharmacological treatment of neuropathic pain syndromes.
Beniczky S; Tajti J; Tímea Varga E; Vécsei L
J Neural Transm (Vienna); 2005 Jun; 112(6):735-49. PubMed ID: 15868394
[TBL] [Abstract][Full Text] [Related]
26. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.
Tanasescu R; Constantinescu CS
Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1219-28. PubMed ID: 23621668
[TBL] [Abstract][Full Text] [Related]
28. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
Horga de la Parte JF; Horga A
Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacological treatment strategy and mirror visual feedback treatment for neuropathic pain].
Sumitani M; Miyauchi S; Yamada Y
Brain Nerve; 2012 Nov; 64(11):1279-86. PubMed ID: 23131739
[TBL] [Abstract][Full Text] [Related]
30. Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management.
Taverner T
Int J Palliat Nurs; 2015 Aug; 21(8):380-4. PubMed ID: 26312533
[TBL] [Abstract][Full Text] [Related]
31. Animal models of neuropathic pain.
Jaggi AS; Jain V; Singh N
Fundam Clin Pharmacol; 2011 Feb; 25(1):1-28. PubMed ID: 20030738
[TBL] [Abstract][Full Text] [Related]
32. EFNS guidelines on pharmacological treatment of neuropathic pain.
Attal N; Cruccu G; Haanpää M; Hansson P; Jensen TS; Nurmikko T; Sampaio C; Sindrup S; Wiffen P;
Eur J Neurol; 2006 Nov; 13(11):1153-69. PubMed ID: 17038030
[TBL] [Abstract][Full Text] [Related]
33. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Dohi T; Morita K; Kitayama T; Motoyama N; Morioka N
Pharmacol Ther; 2009 Jul; 123(1):54-79. PubMed ID: 19393690
[TBL] [Abstract][Full Text] [Related]
34. Lacosamide for the treatment of diabetic neuropathic pain.
Biton V
Expert Rev Neurother; 2008 Nov; 8(11):1649-60. PubMed ID: 18986235
[TBL] [Abstract][Full Text] [Related]
35. Neuropathic pain in soft tissue complaints.
Abrahams MJ
Best Pract Res Clin Rheumatol; 2007 Apr; 21(2):223-44. PubMed ID: 17512480
[TBL] [Abstract][Full Text] [Related]
36. Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence.
Granot R; Day RO; Cohen ML; Murnion B; Garrick R
Pain Med; 2007; 8(1):48-64. PubMed ID: 17244104
[TBL] [Abstract][Full Text] [Related]
37. Challenges relating to the therapeutic management of neuropathic pain.
Alcántara Montero A; González Curado A
Rev Esp Anestesiol Reanim (Engl Ed); 2019 Oct; 66(8):452-453. PubMed ID: 31153594
[No Abstract] [Full Text] [Related]
38. Individualized pharmacological treatment of neuropathic pain.
Helfert SM; Reimer M; Höper J; Baron R
Clin Pharmacol Ther; 2015 Feb; 97(2):135-42. PubMed ID: 25670518
[TBL] [Abstract][Full Text] [Related]
39. Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications.
Patel S; Mittal R; Sarantopoulos KD; Galor A
Expert Opin Ther Targets; 2022 Aug; 26(8):681-695. PubMed ID: 36069761
[TBL] [Abstract][Full Text] [Related]
40. Overcoming clinical challenges of refractory neuropathic pain.
Pirvulescu I; Biskis A; Candido KD; Knezevic NN
Expert Rev Neurother; 2022 Jul; 22(7):595-622. PubMed ID: 35866187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
